Intelligence Platform

Patents

Browse 46 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 10780095

Compositions and methods for treating disorders of circadian and diurnal rhythms using pro

The Regents of the University of California · Granted Tue Sep 22 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10610510

Treatment of circadian rhythm disorders

VANDA PHARMACEUTICALS INC. · Granted Tue Apr 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10456439

NK3 agonist for use in the treatment of a patient suffering from atrial arrhythmia or fibr

ACADEMISCH MEDISCH CENTRUM · Granted Tue Oct 29 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10449176

Treatment of circadian rhythm disorders

VANDA PHARMACEUTICALS INC. · Granted Tue Oct 22 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10196425

Peptide compositions

RHYTHM PHARMACEUTICALS, INC. · Granted Tue Feb 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10167312

Method of treating melanocortin-4 receptor-associated disorders in heterozygous carriers

RHYTHM PHARMACEUTICALS, INC. · Granted Tue Jan 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10149829

Treatment of circadian rhythm disorders

VANDA PHARMACEUTICALS INC. · Granted Tue Dec 11 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9855241

Treatment of circadian rhythm disorders

VANDA PHARMACEUTICALS INC. · Granted Tue Jan 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9845339

Method of treating melanocortin-4 receptor-associated disorders in heterozygous carriers

RHYTHM PHARMACEUTICALS, INC. · Granted Tue Dec 19 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9730910

Treatment of circadian rhythm disorders

VANDA PHARMACEUTICALS INC. · Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9597302

Combination of dofetilide and mexiletine for the prevention and treatment of atrial fibril

Heart Rhythm Solutions, Inc. · Granted Tue Mar 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9549913

Treatment of circadian rhythm disorders

VANDA PHARMACEUTICALS INC. · Granted Tue Jan 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9539234

Treatment of circadian rhythm disorders

VANDA PHARMACEUTICALS INC. · Granted Tue Jan 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9060995

Treatment of circadian rhythm disorders

VANDA PHARMACEUTICALS INC. · Granted Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8912185

Use of glutaric acid derivatives or the pharmaceutically acceptable salts thereof as anti-

OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU “PHARMENTERPRISES” · Granted Tue Dec 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8785492

Treatment of circadian rhythm disorders

VANDA PHARMACEUTICALS INC. · Granted Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8518884

Methods for treating atrial or ventricular arrhythmias by administering a G-protein alpha

Northwestern University · Granted Tue Aug 27 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8450325

Methods for reducing the recurrence of cardiac arrhythmia

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 28 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 23 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8193151

Methods for treating atrial or ventricular arrhythmias

Northwestern University · Granted Tue Jun 05 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 31 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7700600

Methods for treating cardiac arrhythmia

The United States of America · Granted Tue Apr 20 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 6743797

Methods for treating cardiac arrhythmia

The United States of America · Granted Tue Jun 01 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 27 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6439236

Methods for inducing atrial and ventricular rhythms using ultrasound and microbubbles

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue Aug 27 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired